149 related articles for article (PubMed ID: 2551274)
21. Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for delta opioid receptors.
Gacel G; Daugé V; Breuzé P; Delay-Goyet P; Roques BP
J Med Chem; 1988 Oct; 31(10):1891-7. PubMed ID: 2845081
[TBL] [Abstract][Full Text] [Related]
22. Structural requirements for dermorphin opioid receptor binding.
Amiche M; Delfour A; Nicolas P
Int J Pept Protein Res; 1988 Jul; 32(1):28-34. PubMed ID: 2906053
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and pharmacological activity of the N-terminal dermorphin tetrapeptide analogs with CH2-NH peptide bond isosteres.
Salvadori S; Guerrini R; Borea PA; Tomatis R
Int J Pept Protein Res; 1992 Nov; 40(5):437-44. PubMed ID: 1362392
[TBL] [Abstract][Full Text] [Related]
24. Comparative conformational analyses of mu-selective dermorphin and delta-selective deltorphin-II in aqueous solution by 1H-NMR spectroscopy.
Segawa M; Ohno Y; Doi M; Inoue M; Ishida T; Iwashita T
Int J Pept Protein Res; 1994 Sep; 44(3):295-304. PubMed ID: 7822107
[TBL] [Abstract][Full Text] [Related]
25. Delta opioid receptor-selective ligands: [D-Pen2,D-Pen5]enkephalin-dermenkephalin chimeric peptides.
Cavagnero S; Misicka A; Knapp RJ; Davis P; Fang L; Burks TF; Yamamura HI; Hruby VJ
Life Sci; 1991; 49(7):495-503. PubMed ID: 1650414
[TBL] [Abstract][Full Text] [Related]
26. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat.
Negri L; Erspamer GF; Severini C; Potenza RL; Melchiorri P; Erspamer V
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7203-7. PubMed ID: 1353890
[TBL] [Abstract][Full Text] [Related]
27. Cyclic dermorphin-like tetrapeptides with delta-opioid receptor selectivity. 3. Effect of residue 3 modification on in vitro opioid activity.
Mosberg HI; Heyl DL; Haaseth RC; Omnaas JR; Medzihradsky F; Smith CB
Mol Pharmacol; 1990 Dec; 38(6):924-8. PubMed ID: 2174509
[TBL] [Abstract][Full Text] [Related]
28. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
[TBL] [Abstract][Full Text] [Related]
29. Direct electrophilic fluorination of tyrosine in dermorphin analogues and its effect on biological activity, receptor affinity and selectivity.
Labroo VM; Hebel D; Kirk KL; Cohen LA; Lemieux C; Schiller PW
Int J Pept Protein Res; 1991 May; 37(5):430-9. PubMed ID: 1680830
[TBL] [Abstract][Full Text] [Related]
30. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites.
Erspamer V; Melchiorri P; Falconieri-Erspamer G; Negri L; Corsi R; Severini C; Barra D; Simmaco M; Kreil G
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5188-92. PubMed ID: 2544892
[TBL] [Abstract][Full Text] [Related]
31. Opioid receptor binding characteristics and structure-activity studies of novel tetrapeptides in the TIPP (Tyr-Tic-Phe-Phe) series.
Ioja E; Tóth G; Benyhe S; Tourwe D; Péter A; Tömböly C; Borsodi A
Neurosignals; 2005; 14(6):317-28. PubMed ID: 16772734
[TBL] [Abstract][Full Text] [Related]
32. Dermorphin tetrapeptide analogs as potent and long-lasting analgesics with pharmacological profiles distinct from morphine.
Mizoguchi H; Bagetta G; Sakurada T; Sakurada S
Peptides; 2011 Feb; 32(2):421-7. PubMed ID: 21126548
[TBL] [Abstract][Full Text] [Related]
33. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the structural parameters involved in the delta-opioid selectivity of several families of opioid peptides.
Guis C; Bruetschy L; Meudal H; Roques BP; Gacel GA
Int J Pept Protein Res; 1993 Jun; 41(6):576-86. PubMed ID: 8394291
[TBL] [Abstract][Full Text] [Related]
35. Dermorphin analogues carrying an increased positive net charge in their "message" domain display extremely high mu opioid receptor selectivity.
Schiller PW; Nguyen TM; Chung NN; Lemieux C
J Med Chem; 1989 Mar; 32(3):698-703. PubMed ID: 2537427
[TBL] [Abstract][Full Text] [Related]
36. Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides.
Salvadori S; Marastoni M; Balboni G; Borea P; Tomatis R
Int J Pept Protein Res; 1989 Feb; 33(2):94-102. PubMed ID: 2540104
[TBL] [Abstract][Full Text] [Related]
37. Evidence for Pro-dermorphin processing products in rat tissues.
Mor A; Pradelles P; Delfour A; Montagne JJ; Quintero FL; Conrath M; Nicolas P
Biochem Biophys Res Commun; 1990 Jul; 170(1):30-8. PubMed ID: 2196877
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of constrained analogues of the opioid peptide H-Tyr-D-Ala-Phe-Gly-NH2 using the 4-amino-2-benzazepin-3-one scaffold.
Ballet S; Frycia A; Piron J; Chung NN; Schiller PW; Kosson P; Lipkowski AW; Tourwé D
J Pept Res; 2005 Nov; 66(5):222-30. PubMed ID: 16218989
[TBL] [Abstract][Full Text] [Related]
39. Opioid receptor affinity and selectivity effects of second residue and carboxy terminal residue variation in a cyclic disulfide-containing opioid tetrapeptide.
Heyl DL; Omnaas JR; Sobczyk-Kojiro K; Medzihradsky F; Smith CB; Mosberg HI
Int J Pept Protein Res; 1991 Mar; 37(3):224-9. PubMed ID: 1651290
[TBL] [Abstract][Full Text] [Related]
40. Opioid receptor selectivity reversal in deltorphin tetrapeptide analogues.
Lazarus LH; Salvadori S; Tomatis R; Wilson WE
Biochem Biophys Res Commun; 1991 Jul; 178(1):110-5. PubMed ID: 1648906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
